A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. nature.com Submitted by glawgii t3_105wwo9 on January 7, 2023 at 7:10 PM in science 184 comments 1,120
mattjouff t1_j3fi1kg wrote on January 8, 2023 at 4:45 AM That’s a pretty narrow demographic: “prevention in asymptomatic high risk people… “ what about “treatment in symptomatic people at low risk” but I guess it’s valuable to proceed by elimination. Permalink −7− bobbi21 t1_j3ghnhb wrote on January 8, 2023 at 11:40 AM Because those other categories have been well studied already and it doesnt work there either. Permalink Parent 2 [deleted] t1_j3fz6hj wrote on January 8, 2023 at 7:40 AM [removed] Permalink Parent 1
bobbi21 t1_j3ghnhb wrote on January 8, 2023 at 11:40 AM Because those other categories have been well studied already and it doesnt work there either. Permalink Parent 2
Viewing a single comment thread. View all comments